SCHEMBL1779745

SCHEMBL1779745

Cc1cccc(OCC(C)C)c1C#N

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IKBKB O14920 2/20 0.40
CYP1A2 P05177 3/20 0.40
CYP2C19 P33261 1/20 0.40
ALOX15 P16050 1/20 0.40
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
KDM4E B2RXH2 1/20 0.39
SCN4A P35499 4/20 0.39
LMNA P02545 2/20 0.39
SCN1A P35498 2/20 0.39
SCN5A Q14524 2/20 0.39
SCN9A Q15858 2/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
TSHR P16473 1/20 0.39
NFKB1 P19838 1/20 0.39
KCNK3 O14649 1/20 0.39
CACNA1F O60840 1/20 0.39
KCNK2 O95069 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL620764 0.82 ALDH1A1 (0.42) IKBKBNPC1RAB9AXDH
SCHEMBL16951877 0.81 CYP1A2 (0.43) IKBKBCYP1A2CYP2C19ALOX15NPC1
SCHEMBL11855305 0.79 ADRB2 (0.69) CYP1A2LMNASCN1ASCN5ACYP2D6
SCHEMBL16216250 0.78 ALOX15 (0.56) CYP1A2ALOX15KDM4ECYP2D6MAOA
SCHEMBL16962066 0.78 CYP1A2 (0.41) IKBKBCYP1A2CYP2C19NPC1RAB9A
SCHEMBL10087458 0.78 NPC1 (0.47) CYP1A2CYP2C19NPC1RAB9AKDM4E
SCHEMBL16960971 0.77 CYP1A2 (0.43) IKBKBCYP1A2CYP2C19KDM4ELMNA
SCHEMBL19121724 0.77 HTR1B (0.53) CYP1A2RAB9AKDM4ESCN4ALMNA
SCHEMBL8047112 0.76 KDM4E (0.61) CYP1A2CYP2C19ALOX15KDM4ESCN4A
SCHEMBL621031 0.76 NPC1 (0.43) NPC1RAB9AKDM4ELMNAXDH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102020617-B The polymorphs body and preparation method thereof of 2- (3- cyano-4-isobutoxy phenyl) -4- methyl-5-thiazole formic acid 帝人制药株式会社 2019-04-23 CN disclosed
CN-103788012-B A kind of method of preparing Febuxostat Peking Founder Group Co., Ltd. (CN) 2016-05-25 CN disclosed
WO-2012066561-A1 AN IMPROVED PROCESS FOR THE PREPARATION OF 2-ARYLTHIAZOLE DERIVATIVES MATRIX LABORATORIES LTD (IN) 2012-05-24 WO disclosed
US-7943309-B2 Prognosing drug response via presence of allelic variation in human leukocyte antigen; side effect reduction and redirection of therapeutic protocols PHARMIGENE INC. (TW) 2011-05-17 US disclosed
US-20080145846-A1 HLA ALLELES ASSOCIATED WITH ADVERSE DRUG REACTIONS AND METHODS FOR DETECTING SUCH ACADEMIA SINICA (TW) 2008-06-19 US disclosed